CARERUS, INC – Trademark Portfolio

Entity Type: 03

CARERUS, INC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 1 filings in this category. The portfolio also extends into Class 21 (Housewares) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include CARERUS. The owner is based in Fullerton, CA.

150 E. Lambert Road

Fullerton, CA 92835

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CARERUS
CARERUS
Pending 2025
CARERUS
CARERUS
Registered 2022

Trademark Classifications

CARERUS, INC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

20
Furniture (1 filing)

Furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CARERUS, INC have?

CARERUS, INC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does CARERUS, INC file in?

CARERUS, INC files trademarks across 3 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 21 (Housewares), Class 10 (Medical Apparatus). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.

What are CARERUS, INC's most well-known trademarks?

CARERUS, INC's registered trademark portfolio includes well-known marks such as CARERUS. These are among 1 currently registered trademark in the portfolio.

What is CARERUS, INC's trademark registration success rate?

CARERUS, INC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.